Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 20, 2026 9:00 A.M.
Form:
S-3
CIK:
0001534120
Company Name:
Avalo Therapeutics, Inc.
File Number:
333-292614